The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION).
 
Rupesh Kotecha
Honoraria - BrainLAB; Elekta; IBA; InSightec; Kazia Therapeutics; Novocure; ViewRay
Consulting or Advisory Role - Novocure; ViewRay
Speakers' Bureau - GT Medical Technologies (I); Novocure
Research Funding - AstraZeneca (Inst); Blue Earth Diagnostics (Inst); BrainLAB (Inst); Cantex Pharmaceuticals, Inc. (Inst); Exelixis (Inst); GT Medical Technologies (Inst); IBA (Inst); Kazia Therapeutics (Inst); Medtronic (Inst); Novocure (Inst); ViewRay (Inst)
Travel, Accommodations, Expenses - BrainLAB; Elekta; Novocure; ViewRay
Other Relationship - GT Medical Technologies Data Safety Monitoring Board; InSightec Advisory Board; Plus Therapeutics Data Safety Monitoring Board
 
Yazmin Odia
Consulting or Advisory Role - GammaTile; Modifi Bio; PharPoint Research
Research Funding - Bristol-Myers Squibb (Inst); Cantex (Inst); CarThera (Inst); Chimerix (Inst); cns pharmaceuticals (Inst); Exelixis (Inst); MimiVax, LL (Inst); Novocure (Inst); VBI Vaccines (Inst)
 
Zhijian Chen
No Relationships to Disclose
 
Amy Starosciak
Consulting or Advisory Role - Viz.ai
 
Lydia Hodgson
No Relationships to Disclose
 
Alonso La Rosa
Travel, Accommodations, Expenses - GT Medical Technologies
 
Antoinette Pimentel
Employment - Baptist Health South Florida
 
Dilanis Perche
Employment - Miami Cancer Institute at BHSF
Leadership - Miami Cancer Institute at BHSF
 
Matthew Hall
Honoraria - IBA
 
Robert Press
No Relationships to Disclose
 
Manmeet Ahluwalia
Stock and Other Ownership Interests - doctible; MedInnovate Advisors LLC; MimiVax; TriSalus Life Sciences
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - AlloVir; Anheart Therapeutics; Apollomics; Autem Therapeutics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; Equillium; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; Siemens Healhineers/Varian Medical Systems; Sumitomo Dainippon Pharma Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
Other Relationship - Idorsia (I); ResMed (I)
 
Minesh Mehta
Employment - Miami Cancer Institute
Consulting or Advisory Role - AIQ Solutions; Chimeric; Mevion Medical Systems; Novocure; Telix Pharmaceuticals
Patents, Royalties, Other Intellectual Property - WARF patent 14/934,27, TOPICAL VASOCONSTRITOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY